Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Cooking ventilation facilities, Using liquefied gas for cooking, Using solid fuels for cooking, No ventilation during cooking.
- Who it may be relevant to
- Registry conditions: Cardiopulmonary Function, Environmental Exposures. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of Liquefied Petroleum Gas and Ventilation Interventions on Reducing Household Air Pollution From Solid Fuel Use and Improving Cardiopulmonary Health: A Multi-center, 2×2 Factorial Randomized Controlled Trial
Overview
The goal of this clinical trial is to evaluate the independent and synergistic effects of liquefied petroleum gas (LPG) substitution and improved ventilation on household air pollution (HAP) reduction and cardiopulmonary health. The main questions it aims to answer are: 1. Does LPG substitution or improved ventilation reduce HAP and improve cardiopulmonary health? 2. Would the combined intervention of LPG substitution and improved ventilation outperform single interventions? 3. What is the cost-effectiveness of such interventions, and are they sustainable? 4. Does the intervention reduce the incidence of cardiopulmonary clinical events? Participants will be randomized in 4 groups: A: Solid fuel + no ventilation facilities group (300 households): Continued use of solid fuels without installation of ventilation facilities and receipt of standardized health education. No LPG stoves or ventilation equipment will be provided during the intervention period. However, after the primary endpoint assessment at 12 months, all households in Group A will be provided with LPG stoves and ventilation facilities of equivalent specifications free of charge, along with health guidance. Phased cash compensation will be provided during the intervention period. B: Liquefied petroleum gas (LPG) + no ventilation facilities group (300 households): Provided with LPG stoves and instructed to use them during cooking, with regular LPG supply throughout the intervention period. Participants will also receive standardized health education. C: Solid fuel + ventilation facilities group (300 households): Continued use of solid fuels while being provided with ventilation facilities and instructed to use them during cooking. Electricity costs will be compensated during the intervention period. Participants will also receive standardized health education. D: LPG + ventilation facilities group (300 households): Provided with both LPG stoves and ventilation facilities and instructed to use both during cooking. Regular LPG supply and electricity cost compensation will be provided throughout the intervention period. Participants will also receive standardized health education.
Interventions
- Device Cooking ventilation facilities
Installation and use of kitchen ventilation facilities (e.g., range hood) during cooking to reduce indoor air pollution exposure. - Behavioral Using liquefied gas for cooking
Households are provided with liquefied gas stoves and encouraged to use liquefied gas instead of solid fuels for cooking. - Behavioral Using solid fuels for cooking
Households continue using traditional solid fuels (e.g., coal or biomass) for cooking according to their usual practices. - Behavioral No ventilation during cooking
Households continue cooking without installing additional ventilation facilities during the intervention period.
Primary outcome measures
- Change in the Number of Ultrafine particles (UFP) [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Concentrations of PM2.5 [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Heart Rate Variability (HRV) Measured by 12-lead ECG [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Forced Vital Capacity (FVC) [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Forced Expiratory Volume in 1 Second (FEV1) [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
Secondary outcome measures (12)
- Change in the Concentrations of Specific Chemical Components in Particulate Matter [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Concentrations of Ozone (O₃) [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Concentrations of Black Carbon (BC) [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Systolic and Diastolic Blood Pressure [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Fractional Exhaled Nitric Oxide (FeNO) [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Change in the Pulse Wave Velocity (PWV) [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Incidence of Obesity and Central Obesity [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Incidence of Diabetes [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Incidence of Dyslipidemia [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Incidence of Hypertension [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Incidence of Acute Exacerbation of Chronic Bronchitis [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
- Incidence of Acute Respiratory Infection [Time frame: 1 year, with follow-ups at 6, 12, 24, and 36 months]
Eligibility criteria
- Inclusion Criteria Primary Participants:
- Aged 18-75 years;
- Local permanent residents with no plans for long-term travel or relocation within one year;
- Kitchen suitable for installation of ventilation facilities;
- Responsible for daily household cooking, cooking ≥5 times per week;
- To control for community penetration of pollution, households will be preferentially recruited in naturally ventilated, open villages, avoiding valleys or basins that hinder pollutant dispersion; preference for detached houses with ≥10 m distance from neighboring kitchens and well-sealed doors and windows.
Secondary Participants:
- Elderly individuals aged 65-75 living with the primary participant;
- Children aged 3-6 living in the same household.
- Exclusion Criteria:
- Clinical diagnosis of major chronic diseases such as severe respiratory diseases, cardiovascular diseases, malignant tumors, or end-stage renal disease;
- Pregnant or breastfeeding women;
- Current smokers or individuals with self-reported exposure to productive dust or other occupational hazards;
- Individuals who are unable to fully understand the study process or clearly express their own complaints, such as those with psychiatric disorders or severe neuroses, or who cannot cooperate with the study for other reasons.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
China · 3 centers
- Suiping County Health Center — Zhumadian
- Hong'an County Health Center — Huanggang
- Longhui County Health Center — Shaoyang
Identifiers
NCT: NCT07005193 · 2023ZD0509900